Amgen Inc (AMGN · NASDAQ)
AMGN · MARKET VIEW
Market view · as of Jul 13, 2026
Revenue (TTM)
$37.22B
+5.8% YoY
Gross margin
71.4%
EPS (latest q)
$5.15
vs $4.77 est · beat
52-wk position
81.8%
-5.7% vs 52w high · +7.6% 1mo
Price (last ~year)
Amgen Inc. (AMGN) maintains a $196.12 billion market capitalization, supported by $37.22 billion in trailing twelve-month revenue and a 71.4% gross margin. The company has surpassed earnings estimates for four consecutive quarters, most recently reporting $5.15 per share for the period ending March 31, 2026. With $57.32 billion in total debt and a 3.4x debt-to-EBITDA ratio, the stock has risen 7.6% over the past month to close at $363.39.
Valuation
- Market cap
- $196.12B
- P/E
- 25.32
- PEG
- 1.992
- P/B
- 21.34
- P/S
- 5.27
- EV/EBITDA
- 14.48
- Beta
- 0.403
- Analyst target
- $355.76
Quality & returns
- Gross margin
- 71.4%
- Operating margin
- 33.8%
- Profit margin
- 21.0%
- ROE
- 101.3%
- ROA
- 8.3%
Price movement
- Last
- $363.39
- 1-month
- +7.6%
- 3-month
- +4.3%
- RSI (14)
- 75
- vs SMA200
- +8.8%
- 52-wk position
- 81.8% -5.7% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-03-31 | $8.62B | $2.67B | $1.82B | $3.86B |
| 2025-12-31 | $9.90B | $3.94B | $1.33B | $3.30B |
| 2025-09-30 | $9.56B | $2.53B | $3.22B | $5.91B |
| 2025-06-30 | $9.17B | $2.64B | $1.43B | $3.62B |
Recent news
- Somewhat-Bullish Health Check: Immutep shares bounce on revived lung cancer treatment hopes · 2026-07-13
- Neutral Castleview Partners LLC Has $2.77 Million Position in Amgen Inc. $AMGN · 2026-07-12
- Neutral Amgen Inc. $AMGN Shares Acquired by Ferguson Wellman Capital Management Inc. · 2026-07-12
- Neutral Cullinan Associates Inc. Has $8.98 Million Stock Holdings in Amgen Inc. $AMGN · 2026-07-12
- Somewhat-Bullish Fifth Third Bancorp Acquires 167,835 Shares of Amgen Inc. $AMGN · 2026-07-12
- Somewhat-Bullish Amgen stock steadies as the biotech group leans on scale · 2026-07-12
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)